Understand, predict, engineer
Ben Lehner joins the Sanger Institute as a new Senior Group Leader. He seeks to lay the foundations for programmable biology.
A lasting legacy
Meet the next generation of genomic scientists who are benefiting from our founder's generosity
DECIPHER: Fuelling Rare Disease Research
More than 15 years ago, a hospital doctor realised that bringing people’s genetic data together could provide answers for families affected by rare diseases. With the help of the Sanger Institute, the DECIPHER project has been helping families ever since
Day in the life: Software Developer – making research happen
Meet the people building software to enable high-throughput genomics at the Sanger Institute.
Science in a conflict zone: Investigating cholera in Yemen
In addition to the civil war, Yemen is experiencing the worst epidemic of cholera ever recorded. We spoke to Ankur Rakesh, a volunteer doctor with Médecins Sans Frontières (MSF) / Doctors Without Borders, who travelled to Yemen in July 2017 to study the genomics of this highly infectious and deadly disease
A new deal on data – articulating the contract between science and people
Now is the time for scientists to strike a deal everyone that benefits society as well as research, argue Anna Middleton, Vivienne Parry and Julian Borra
Chief Medical Officer’s annual report 2016: Generation Genome highlights the potential for pathogen genomics in patient diagnosis and infection control
04.07.17 The UK Chief Medical Officer's Report has highlighted the vital role genetics and genomics will play in UK NHS healthcare and medicine. Professor Sharon Peacock helped write the report's chapter on Infectious disease.
